Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-136411
Filing Date
2021-11-09
Accepted
2021-11-09 17:41:38
Documents
1
Period of Report
2021-11-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131118-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2131118-10_4seq1.xml 4 14068
  Complete submission text file 0001104659-21-136411.txt   15652
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

EIN.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O G1 THERAPEUTICS, 700 PARK OFFICES DR SUITE 200, P.O. BOX 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address
Flowers Cynthia Louise (Reporting) CIK: 0001741455 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 211393505